| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $16.7M | — | +64.9% |
| Cost of Revenue | $3.7M | — | +59.0% |
| Gross Profit | $13.0M | — | +66.7% |
| R&D Expense | $3.8M | — | +137.1% |
| SG&A Expense | $18.2M | — | +73.4% |
| Operating Income | -$9.0M | — | -109.0% |
| Pre-tax Income | -$8.4M | — | -79.7% |
| Income Tax | $0 | — | — |
| Net Income | -$8.4M | — | -79.7% |
| EPS (Basic) | -$0.41 | — | +99.2% |
| EPS (Diluted) | -$0.41 | — | +99.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.5M | -57.2% | — |
| Accounts Receivable | $10.5M | +27.6% | — |
| Inventory | $21.8M | +1.1% | — |
| Current Assets | $145.8M | -7.2% | — |
| Total Assets | $160.4M | -5.6% | — |
| Current Liabilities | $12.3M | -13.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.4M | — | -90.8% |
| Capital Expenditures | $2.7M | — | +224.4% |
| Investing Cash Flow | -$3.1M | — | +76.1% |
| Financing Cash Flow | $101K | — | -99.5% |
| Free Cash Flow | -$15.1M | — | -106.2% |
| Long-term Debt | $15.0M | +0.3% | — |
| Total Liabilities | $27.3M | -6.2% | — |
| Stockholders' Equity | $133.0M | -5.5% | +324.3% |